静脉注射甲泼尼龙治疗多发性硬化症的早期免疫抑制作用 - Suppr | 超能文献

Early immunosuppressive effect of parenteral methylprednisolone in the treatment of multiple sclerosis.

作者信息

Durelli L, Baggio G F, Bergamasco B, Barile C, Cocito D, Delsedime M, Perla F, Riccio A, Bergamini L

出版信息

Acta Neurol (Napoli). 1985 Jun-Aug;7(3-4):338-44.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Early immunosuppressive effect of parenteral methylprednisolone in the treatment of multiple sclerosis.静脉注射甲泼尼龙治疗多发性硬化症的早期免疫抑制作用

Acta Neurol (Napoli). 1985 Jun-Aug;7(3-4):338-44.

2

[Our experiences in the treatment of multiple sclerosis by intrathecal administration of methylprednisolone acetate and follow-up of the cerebrospinal fluid changes during this treatment].

Cesk Neurol Neurochir. 1975 Dec;38(6):338-45.

3

[Effect of treatment with Encorton (Polfa), Solu-Medrol and Encorton and Cyclophosphamide and Encorton on the production of immunoglobulin G in the central nervous system in multiple sclerosis].[恩考通（波兰法玛）、甲泼尼龙、恩考通与环磷酰胺联合治疗对多发性硬化症中枢神经系统中免疫球蛋白G产生的影响]

Wiad Lek. 1989 Dec 1;41(23):1579-83.

4

Intrathecal methylprednisolone acetate in multiple sclerosis treatment. Clinical evaluation.

Acta Neurol Belg. 1983 Aug-Oct;83(4):190-6.

5

High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations.大剂量静脉注射甲基强的松龙治疗多发性硬化症：临床与免疫学相关性

Neurology. 1986 Feb;36(2):238-43. doi: 10.1212/wnl.36.2.238.

6

[Multiple sclerosis. Clinico-statistical results of therapy based on intrathecal methylprednisolone acetate].

Minerva Med. 1974 Sep 19;65(65):3407-11.

7

[Our contemporary experiences with the intrathecal treatment of multiple sclerosis using depot corticoids. II. Results in cerebrospinal fluid].[我们使用长效皮质类固醇进行鞘内注射治疗多发性硬化症的当代经验。II. 脑脊液中的结果]

Cesk Neurol Neurochir. 1974 Sep;37(5):293-300.

8

[Our contemporary experiences with the intrathecal treatment of multiple sclerosis using depot corticoids. I. Clinical results].[我们当代使用长效皮质类固醇进行鞘内注射治疗多发性硬化症的经验。I. 临床结果]

Cesk Neurol Neurochir. 1974 Sep;37(5):287-92.

9

Double-blind trial of dexamethasone versus methylprednisolone in multiple sclerosis acute relapses.地塞米松与甲泼尼龙治疗多发性硬化急性复发的双盲试验

Eur Neurol. 1994;34(4):199-203. doi: 10.1159/000117038.

10

A double-blind clinical trial of mitoxantrone versus methylprednisolone in relapsing, secondary progressive multiple sclerosis.米托蒽醌与甲泼尼龙治疗复发型继发进展型多发性硬化的双盲临床试验。

Acta Neurol Belg. 2001 Dec;101(4):210-6.

引用本文的文献

1

Efficacy, safety, and quality-of-life of treatments for acute relapses of multiple sclerosis: results from a literature review of randomized controlled trials.多发性硬化急性复发治疗的疗效、安全性及生活质量：随机对照试验文献综述结果

Degener Neurol Neuromuscul Dis. 2019 Jul 1;9:55-78. doi: 10.2147/DNND.S208815. eCollection 2019.

2

Clinical experience with repository corticotropin injection in patients with multiple sclerosis experiencing mood changes with intravenous methylprednisolone: a case series.长效促肾上腺皮质激素注射液治疗多发性硬化症患者静脉注射甲基泼尼松龙后出现情绪变化的临床经验：病例系列

Ther Adv Neurol Disord. 2016 May;9(3):189-97. doi: 10.1177/1756285615618642. Epub 2015 Dec 7.

3

Corticosteroids or ACTH for acute exacerbations in multiple sclerosis.用于多发性硬化急性加重期的皮质类固醇或促肾上腺皮质激素。

Cochrane Database Syst Rev. 2000;2000(4):CD001331. doi: 10.1002/14651858.CD001331.